Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Advent to Acquire Sanofi's Generics Biz in Europe | Contract Pharma

What are you searching for?

Sign in
Breaking News

Advent to Acquire Sanofi’s Generics Biz in Europe

Sanofi and Advent finalize negotiations for the acquisition of Zentiva

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent. The companies have signed a Share Purchase Agreement worth €1.9 billion. The companies announced that they had entered into exclusive talks on April 17, 2018.

The signing of this Share Purchase Agreement marks a critical step on the way to the closing of the deal and the transfer of the Zentiva business to Advent, that is anticipated during the course of the fourth quarter of 2018.

The transaction remains subject to the approval of the competent regulatory authorities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters